Table. 1.
Socio demographic and clinical profile longitudinal cohort of initially IGRA+ pregnant women
| Characteristics | Overall n=165 | H1V+ n=35 | H1V−n=130 |
|---|---|---|---|
| Sociodemographic features | |||
| Age in years, Median (1QR) | 23 (21 – 27) | 26 (22 – 30) | 22 (20 – 26) * |
| Urban residence, n (%) | 155 (93%) | 28 (80%) | 127 (98%) * |
| Household income: $1–5/day, n (%) | 55 (33%) | 17 (49%) | 38 (29%) * |
| Unemployed (Housewife), n (%) | 140 (85%) | 26 (74%) | 114 (88%) |
| Socioeconomic Status (modified Kuppuswamy scale) | |||
| Lower | 100 (61%) | 26 (74%) | 74 (57%) |
| Middle/Upper | 65 (39%) | 9 (26%) | 56 (43%) |
| One room tenement, n (%) | 63 (38%) | 19 (54%) | 44 (34%) * |
| Live with >3 family members, n (%) | 80 (49%) | 11 (31%) | 69 (53%) * |
| Education ≤ to 4th grade, n (%) | 40 (24%) | 14 (40%) | 26 (20%) * |
| Clinical features and relevant laboratory results | |||
| Gestational age at entry, Median (1QR) | 22 (18 – 27) | 23 (18 – 29) | 21 (18 – 26) |
| Gestational age at delivery | |||
| Preterm | 15 (9%) | 5 (14%) | 10 (8%) |
| Term | 147 (91%) | 30 (86%) | 117 (92%) |
| BCG vaccinated | 127 (77%) | 27 (77.1%) | 100 (76.9%) |
| BCG given | |||
| > 10 yrs ago | 120 (72.7%) | 25 (71.4%) | 95 (73.1%) |
| Don’t Know | 45 (27.3%) | 10 (28.6%) | 35 (26.9%) |
| Past H/O TB-previous 2 years | 5 (3.0%) | 3 (8.6%) | 2 (1.5%) |
| Mid-upper arm circumference | |||
| Normal ≥ 22 – 27 cms | 93 (56%) | 23 (66%) | 70 (54%) |
| Underweight < 22 cms | 41 (25%) | 6 (17%) | 35 (27%) |
| Overweight > 27 – 31 cms | 26 (16%) | 5 (14%) | 21 (16%) |
| Obese ≥ 31 cms | 5 (3%) | 1 (3%) | 4 (3%) |
| Anemia | |||
| Hemoglobin < 9 gm/dL | 17 (10%) | 6 (17%) | 11 (8%) |
| Tuberculin skin test | |||
| Positive | 115 (69.7%) | 17 (48.6%) | 98 (75.4%)* |
| ≥5mm &<10mm | 1 (0.9%) | 0 | 1 (1.0%) |
| > 10mm | 114 (99.1%) | 17 (100%) | 97 (99%) |
| CD4/mm3, Median (1QR)a | - | 476 (399 – 586) | NA |
| Median H1V viral load a copies/mL (1QR) | - | < 40 (0 – 109) | NA |
| H1V viral load > 400 copies | - | 4 (11%) | NA |
| On ART at enrollment a | - | 35 (100%) | NA |
All data presented as number (%) unless otherwise indicated.
*
Significant at <0.05
Abbreviations: ART, antiretroviral treatment; HIV, human immunodeficiency virus; IQR, interquartile range
a
Data is presented for women with HIV (n=35)